GeneDx Holdings (WGS) Hit with Securities Class Action Following 49% Stock Collapse — HBSS
Hagens Berman announced it is investigating a securities class action against GeneDx Holdings, alleging the company misled investors regarding the Fabric Genomics acquisition. The lawsuit follows a 49% stock collapse after the company reported a $31.2 million impairment charge and slashed 2026 revenue guidance by 12%.
Key figures
- Revenue miss
- 2500000
- Guidance cut pct
- 12%
- Impairment charge
- 31200000
- Stock decline pct
- 49%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.